Skip to: Content | Navigation | Sub Navigation

MRSAid for Nasal Decolonization

Product ImageMRSAid™ is a novel, non-antibiotic therapy for nasal bacterial decolonization to reduce the incidence of healthcare-acquired infections (HAI’s). MRSAid™ is based on the technology “Photodisinfection”, and consists of the application of a topical photosensitizer solution in the nasal passages of individuals colonized with potentially pathogenic bacteria such as methicillin-resistant Staphylococcus aureus (MRSA). This solution is subsequently activated locally using non-thermal visible light energy. The treatment is painless, does not lead to bacterial resistance, and can decolonize the nose of Methicillin Resistant Staphylococcus aureus in a single several minute treatment.* As such, MRSAid™ is the first non-antibiotic solution for directly treating bacteria in the nose; which is the primary reservoir in humans for MRSA colonization.

* Nasal swabs and cultures, both before and after MRSAid™ treatment, have shown that carriers can be rendered plate negative for MRSA after a single several minute treatment.